Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol in Parkinson's Disease Dementia
NCT02914366Phase 2Active, not recruiting
- Start
- Nov 2015
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambroxol in Parkinson's disease dementia (PDD). Started Nov 2015; status: active, not recruiting.
02
Drugs
ambroxol
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT02914366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02914366.